The Weill Cornell Medical College Class of 2021 learned on national Match Day, March 19, where they will be doing their internship and residency training, during the next several years of their medical careers.
In the next webinar of the College of Arts and Sciences’ yearlong series, “Racism in America,” panelists will focus on the impact of racism on access to health care and health outcomes, March 29 at 7 p.m.
Cancer cells can dodge chemotherapy by entering a type of “active hibernation” that enables them to weather the stress induced by aggressive treatments, according to a new study by scientists at Weill Cornell Medicine.
A team led by scientists at Weill Cornell Medicine has made a map identifying all the different RNA molecules that are derived from each gene in the brains of mice.
Supported by a grant from the NIH, researchers from Weill Cornell Medicine and the University of Miami will study ways to use wastewater as an early warning and mapping system for genetic variants of the virus that causes COVID-19.
A $30 million commitment from David R. Atkinson ’60 and Patricia Atkinson will name a new multidisciplinary building on campus, intended to foster innovative and collaborative research in key university priority areas.
The Office of Academic Integration has awarded $750,000 in seed grants to 10 studies ranging from refugee health and legal rights, to a vaccine treating fentanyl addiction and overdose, to pancreatic cancer and antibiotic tolerance.
In an expansion of its biomedical education curricula, Weill Cornell Medicine is launching an additional site for graduate programs at Houston Methodist for the 2021-22 academic year.
A new study identifies the mechanism for tolerance to penicillin and related antibiotics in bacteria, findings that could lead to new therapies that boost the effectiveness of these treatments.
